Summary: Background: Early trials of long-term lenalidomide use reported an increased incidence of second primary malignancy (SPM). including acute myeloid leukaemia and myelodysplastic syndrome. Later. meta-analysis suggested the link to be secondary to lenalidomide in combination with melphalan. https://www.findingthestory.com/product-category/tool-organizer/
Tool Organizer
Internet 1 hour 18 minutes ago lpzxuavmr4fu08Web Directory Categories
Web Directory Search
New Site Listings